Your browser doesn't support javascript.
loading
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma.
Zhou, Jin; Wu, Zhong; Zhang, Zhouwei; Goss, Louisa; McFarland, James; Nagaraja, Ankur; Xie, Yingtian; Gu, Shengqing; Peng, Ke; Zeng, Yong; Zhang, Xiaoyang; Long, Henry; Nakagawa, Hiroshi; Rustgi, Anil; Diehl, J Alan; Meyerson, Matthew; Wong, Kwok-Kin; Bass, Adam.
Afiliación
  • Zhou J; Department of Surgery, West China Hospital, Sichuan University, Chendu, Sichuan Province, China.
  • Wu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zhang Z; Department of Surgery, West China Hospital, Sichuan University, Chendu, Sichuan Province, China ab5147@cumc.columbia.edu Zhong_wu@dfci.harvard.edu.
  • Goss L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • McFarland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Nagaraja A; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Xie Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gu S; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Peng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zeng Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhang X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Long H; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.
  • Nakagawa H; Department of Biostatistics, Harvard T.H.Chan School of Public Health, Boston, MA, USA.
  • Rustgi A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Diehl JA; Department of Surgery, West China Hospital, Sichuan University, Chendu, Sichuan Province, China.
  • Meyerson M; Department of Oncologic Sciences, Huntsman Cancer Institute; University of Utah, Salt Lake City, Utah, USA.
  • Wong KK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bass A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Gut ; 71(4): 665-675, 2022 04.
Article en En | MEDLINE | ID: mdl-33789967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gut Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gut Año: 2022 Tipo del documento: Article País de afiliación: China